UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myeloid‐derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy

Journal of leukocyte biology, 2017-09, Vol.102 (3), p.727-740

2017

Volltextzugriff (PDF)

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Journal of clinical oncology, 2021-08, Vol.39 (24), p.2656-2666

2021

Volltextzugriff (PDF)

Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study

Clinical cancer research, 2020-10, Vol.26 (19), p.5153-5161

2020

Volltextzugriff (PDF)

Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial

Journal for immunotherapy of cancer, 2023-05, Vol.11 (5), p.e006270

2023

Volltextzugriff (PDF)

Plasma Thermogram Parameters Differentiate Status and Overall Survival of Melanoma Patients

Current oncology (Toronto), 2023-06, Vol.30 (7), p.6079-6096

2023

Volltextzugriff (PDF)

Tumor-infiltrating lymphocyte therapy in metastatic melanoma

Clinical advances in hematology & oncology, 2023-01, Vol.21 (1), p.49

Chesney, Jason A

2023

Volltextzugriff (PDF)

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion

Journal of translational medicine, 2012-11, Vol.10 (1), p.236-236, Article 236

2012

Volltextzugriff (PDF)

Open-label, phase II study of talimogene laherparepvec plus pembrolizumab for the treatment of advanced melanoma that progressed on prior anti–PD-1 therapy: MASTERKEY-115

European journal of cancer (1990), 2024-08, Vol.207, p.114120, Article 114120

2024

Volltextzugriff (PDF)

PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells

Molecular and cellular biochemistry, 2020-07, Vol.470 (1-2), p.115-129

2020

Volltextzugriff (PDF)

Single-Cell Immune Mapping of Melanoma Sentinel Lymph Nodes Reveals an Actionable Immunotolerant Microenvironment

Clinical cancer research, 2022-05, Vol.28 (10), p.2069-2081

2022

Volltextzugriff (PDF)

25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor Angiogenesis

Molecular medicine (Cambridge, Mass.), 2015-10, Vol.21 Suppl 1 (S1), p.S19-S24

2015

Volltextzugriff (PDF)

Thermal liquid biopsy for monitoring melanoma patients under surveillance during treatment: A pilot study

Biochimica et biophysica acta. General subjects, 2018-08, Vol.1862 (8), p.1701-1710

2018

Volltextzugriff (PDF)

Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy

Science advances, 2023-06, Vol.9 (26), p.eadg3736-eadg3736

2023

Volltextzugriff (PDF)

6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitro

Biochemical and biophysical research communications, 2017-03, Vol.484 (3), p.687-693

2017

Volltextzugriff (PDF)

Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival

Metabolomics, 2022-05, Vol.18 (5), p.31-31, Article 31

2022

Volltextzugriff (PDF)

5-(3,3-Dimethyle-1-Triazeno) Imidazole-4-Carboxamide and Interleukin-2 Adjuvant Therapy in Resected High-Risk Primary and Regionally Metastatic Melanoma

The American journal of the medical sciences, 2019-01, Vol.357 (1), p.43-48

2019

Volltextzugriff (PDF)

Longitudinal Relationship between Idylla Plasma ctBRAF V600 Mutation Detection and Tumor Burden in Patients with Metastatic Melanoma

Molecular diagnosis & therapy, 2021-05, Vol.25 (3), p.361-371

2021

Volltextzugriff (PDF)

Glucose Availability and Glycolytic Metabolism Dictate Glycosphingolipid Levels

Journal of cellular biochemistry, 2015-01, Vol.116 (1), p.67-80

2015

Volltextzugriff (PDF)

776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A873-A873

2023

Volltextzugriff (PDF)

Digitalis, A Targeted Therapy for Cancer?

The American journal of the medical sciences, 2009-05, Vol.337 (5), p.355-359

2009

Volltextzugriff (PDF)

Bacterial glutathione: a sacrificial defense against chlorine compounds

Journal of Bacteriology, 1996-04, Vol.178 (7), p.2131-2135

1996

Volltextzugriff (PDF)

MIF expression in the rat brain: implications for neuronal function

Molecular medicine (Cambridge, Mass.), 1998-04, Vol.4 (4), p.217-230

1998

Volltextzugriff (PDF)

Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessary

American journal of clinical oncology, 2009-08, Vol.32 (4), p.429-431

2009

Volltextzugriff (PDF)

Abstract 1772: EGFR signaling as a mechanism of resistance to CDK4/6 inhibitors in Palbociclib-resistant ER+ breast cancer cells

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1772-1772

2022

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(192)

Publikationsform

Sprache

Englisch
(211)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Myeloid‐derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study

Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial

Plasma Thermogram Parameters Differentiate Status and Overall Survival of Melanoma Patients

Tumor-infiltrating lymphocyte therapy in metastatic melanoma

Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion

Open-label, phase II study of talimogene laherparepvec plus pembrolizumab for the treatment of advanced melanoma that progressed on prior anti–PD-1 therapy: MASTERKEY-115

PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells

Single-Cell Immune Mapping of Melanoma Sentinel Lymph Nodes Reveals an Actionable Immunotolerant Microenvironment

25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor Angiogenesis

Thermal liquid biopsy for monitoring melanoma patients under surveillance during treatment: A pilot study

Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy

6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitro

Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival

5-(3,3-Dimethyle-1-Triazeno) Imidazole-4-Carboxamide and Interleukin-2 Adjuvant Therapy in Resected High-Risk Primary and Regionally Metastatic Melanoma

Longitudinal Relationship between Idylla Plasma ctBRAF V600 Mutation Detection and Tumor Burden in Patients with Metastatic Melanoma

Glucose Availability and Glycolytic Metabolism Dictate Glycosphingolipid Levels

776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study

Digitalis, A Targeted Therapy for Cancer?

Bacterial glutathione: a sacrificial defense against chlorine compounds

MIF expression in the rat brain: implications for neuronal function

Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessary

Abstract 1772: EGFR signaling as a mechanism of resistance to CDK4/6 inhibitors in Palbociclib-resistant ER+ breast cancer cells

Suchergebnisse filtern